Ionic Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Ionic Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-93,626	Closed	-$2.42M	–	214
2018 Q2	$2.42M	Sell	93,626 -46,422	-33%	-$1.2M	0.14%	90
2018 Q1	$3.14M	Sell	140,048 -67,079	-32%	-$1.64M	0.2%	100
2017 Q4	$5.19M	Sell	207,127 -19,837	-9%	-$486K	0.21%	111
2017 Q3	$5.49M	Sell	226,964 -7,000	-3%	-$165K	0.22%	92
2017 Q2	$4.73M	Buy	233,964 +64,100	+38%	+$1.34M	0.25%	107
2017 Q1	$4.57M	Buy	+169,864	New	+$3.47M	0.28%	104

Other funds holding FLXN

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Ionic Capital Management's FLXN Position: Q3 2018 in Review

Ionic Capital Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q3 2018, closing a stake of 93,626 shares — an estimated $2.42M sold.

Ionic Capital Management first reported a position in FLXN in Q1 2017 and held it in 6 quarters. The position peaked at $5.49M in Q3 2017. 129 funds tracked by Wall St. Rank hold FLXN as of Q3 2018.

Ionic Capital Management reported no remaining Flexion Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
Ionic Capital Management sold 93,626 Flexion Therapeutics, Inc. shares in Q3 2018, an estimated $2.42M.
Ionic Capital Management first reported a position in Flexion Therapeutics, Inc. in Q1 2017 and held it in 6 quarters.
Ionic Capital Management's Flexion Therapeutics, Inc. position peaked at $5.49M in Q3 2017.
129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q3 2018.

Based on Ionic Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.